Drug Profile
ARL 57
Alternative Names: ARL 57 CLLatest Information Update: 14 Oct 1994
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim Pharma KG
- Class Cardiotonics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 14 Oct 1994 Discontinued-Unspecified phase in Heart failure in Germany (Unknown route)